SLC30A3 and cancer: In contrast, overexpression of SLC30A3 in HuTu80 resulted in an ~3.3 times lower IC50 of cisplatin, which suggests greater cancer cell sensitivity to chemotherapy associated with this gene expression (Figure 8E, Table 1).